The study on the relationship between IRS-1 Gly972Arg and IRS-2 Gly1057Asp polymorphisms and type 2 diabetes in the Kurdish ethnic group in west Iran

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 11, 2012, Pages 1270-1276

  Haghani, Karimeh ^a   Bakhtiyari, Salar ^a  

^a ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; GENOTYPE; GLUCOSE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84868010330     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0160     Document Type: Article

References (35)

1. Almind K, Bjorbaek C, Vestergaard H, et al. (1993) Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulindependent diabetes mellitus. Lancet 342:828-832. (Pubitemid 23285910)
2. Almind K, Inoue G, Pedersen O, et al. (1996) A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 97:2569-2575.
3. American Diabetes Association (1997) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197.
4. Bakhtiyari S, Meshkani R, Taghikhani M, et al. (2010) Protein tyrosine phosphatase-1B (PTP-1B) knockdown improves palmitate-induced insulin resistance in C2C12 skeletal muscle cells. Lipids 45:237-244.
5. Bektas A, Warram JH, White MF, et al. (1999) Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes. Diabetes 48:640-642. (Pubitemid 29106882)
6. Bodhini D, Radha V, Deepa R, et al. (2007) The G1057D polymorphism of IRS-2 gene and its relationship with obesity in conferring susceptibility to type 2 diabetes in Asian Indians. Int J Obes (Lond) 31:97-102. (Pubitemid 46006021)
7. Burguete-Garcia AI, Cruz-Lopez M, Madrid-Marina V, et al. (2010) Association of Gly972Arg polymorphism of IRS1 gene with type 2 diabetes mellitus in lean participants of a national health survey in Mexico: a candidate gene study. Metabolism 59:38-45.
8. D'Alfonso R, Marini MA, Frittitta L, et al. (2003) Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes. J Clin Endocrinol Metab 88:317-322. (Pubitemid 36115183)
9. El Mkadem SA, Lautier C, Macari F, et al. (2001) Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 50:2164-2168. (Pubitemid 33643687)
10. Florez JC, Sjogren M, Burtt N, et al. (2004) Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes. Diabetes 53:3313-3318. (Pubitemid 39564509)
11. Goldstein BJ (2002) Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 90:3G-10G. (Pubitemid 35266675)
12. Hager J, Zouali H, Velho G, et al. (1993) Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families. Lancet 342:1430. (Pubitemid 23361267)
13. Hamman RF (1992) Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8:287-338. (Pubitemid 23171181)
14. Hribal ML, Federici M, Porzio O, et al. (2000) The Gly/Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab 85:2004-2013. (Pubitemid 32269313)
15. Ito K, Katsuki A, Furuta M, et al. (1999) Insulin sensitivity is not affected by mutation of codon 972 of the human IRS-1 gene. Horm Res 52:230-234. (Pubitemid 30303715)
16. Jellema A, Zeegers MP, Feskens EJ, et al. (2003) Gly972Arg variant in the insulin receptor substrate-1 gene and association with type 2 diabetes: a meta-analysis of 27 studies. Diabetologia 46:990-995. (Pubitemid 36961324)
17. Kalidas K, Wasson J, Glaser B, et al. (1998) Mapping of the human insulin receptor substrate-2 gene, identification of a linked polymorphic marker and linkage analysis in families with type II diabetes: no evidence for a major susceptibility role. Diabetologia 41:1389-1391. (Pubitemid 28488769)
18. Mammarella S, Romano F, Di Valerio A, et al. (2000) Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. Hum Mol Genet 9:2517-2521.
19. Marini MA, Frontoni S, Mineo D, et al. (2003) The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 88:3368-3371. (Pubitemid 36877518)
20. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419. (Pubitemid 15018832)
21. McCarthy MI, Hattersley AT (2001) Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes. Expert Rev Mol Diagn 1:403-412. (Pubitemid 34654420)
22. Okazawa K, Yoshimasa Y, Miyamoto Y, et al. (2005) The haplotypes of the IRS-2 gene affect insulin sensitivity in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 68: 39-48. (Pubitemid 40461885)
23. Ouederni TB, Sanchez-Corona J, Flores Martinez SE, et al. (2009) The G1057D polymorphism of IRS-2 gene is not associated with type 2 diabetes and obese patients among ethnic groups in Tunisian population. Clin Biochem 42:1169-1173.
24. Porzio O, Federici M, Hribal ML, et al. (1999) The Gly972/Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J Clin Invest 104:357-364.
25. Rosskopf D, Frey U, Eckhardt S, et al. (2000) Interaction of the G protein beta 3 subunit T825 allele and the IRS-1 Arg972 variant in type 2 diabetes. Eur J Med Res 5:484-490.
26. Saberi H, Mohammadtaghvaei N, Gulkho S, et al. (2011) The ENPP1 K121Q polymorphism is not associated with type 2 diabetes and related metabolic traits in an Iranian population. Mol Cell Biochem 350:113-118.
27. Sesti G, Federici M, Hribal ML, et al. (2001) Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. Faseb J 15:2099-2111. (Pubitemid 32927927)
28. Stefan N, Kovacs P, Stumvoll M, et al. (2003) Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. Diabetes 52:1544-1550. (Pubitemid 36666212)
29. Toye A, Gauguier D (2003) Genetics and functional genomics of type 2 diabetes mellitus. Genome Biol 4:241.
30. van Dam RM, Hoebee B, Seidell JC, et al. (2004) The insulin receptor substrate-1 Gly972Arg polymorphism is not associated with type 2 diabetes mellitus in two population-based studies. Diabet Med 21:752-758. (Pubitemid 38916221)
31. Wang H, Rissanen J, Miettinen R, et al. (2001) New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes 50:1949-1951. (Pubitemid 33641618)
32. White MF (2002) IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283:E413-E422. (Pubitemid 35230477)
33. Whittemore AS (1996) Genome scanning for linkage: an overview. Am J Hum Genet 59:704-716. (Pubitemid 26269049)
34. Withers DJ, Gutierrez JS, Towery H, et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904. (Pubitemid 28157668)
35. Zeggini E, Parkinson J, Halford S, et al. (2004) Association studies of insulin receptor substrate 1 gene (IRS1) variants in type 2 diabetes samples enriched for family history and early age of onset. Diabetes 53:3319-3322. (Pubitemid 39564510)